- ATC has a rapidly progressive course and early dissemination
- The most common sites of distant spread include, in descending order:
- The lung, bone, and brain
- Metastases, particularly in the lung:
- Are likely to be present at diagnosis in more than 50% of cases
- The overall 5-year survival rate:
- Is reportedly less than 10%, and most patients do not live longer than a few months after diagnosis
- One study has shown that patients younger than 60 years who have ATC confined to the thyroid:
- Have a better prognosis than patients who are older and have distant metastases
- A retrospective study from Korea found that:
- Age less than 60 years, tumor size less than 7 cm, and lesser extent of disease:
- Were independent predictors of lower disease-specific mortality
- Age less than 60 years, tumor size less than 7 cm, and lesser extent of disease:
- While some studies have suggested that postoperative radiotherapy:
- May be of benefit in terms of survival, definitive prospective trials are lacking
- Akaishi et al conducted a review of 100 patients with ATC in a single hospital (Ito Hospital) from 1993-2009:
- The 1-year survival rates were as follows:
- Stage IVA – 72.7%
- Stable IVB- 24.8%
- Stable IVC – 8.2%
- The 1-year survival rates were as follows:
- Multivariate analysis demonstrated worse prognosis with:
- Age older than 70 years, white blood cell count of 10,000/μL or more, extrathyroidal invasion, and distant metastases at the time of diagnosis
- Survival was significantly better if the patient received complete resection, external radiation at doses of 40 Gy or more, or both
- Orita et al developed a prognostic index that can predict prognosis and assist in the early treatment of ATC
#Arrangoiz #ThyroidSurgeon #CancerSurgeon #SurgicalOncologist #HeadandNeckSurgeon #EndocrineSurgery #ThyroidCancer #Miami #Mexico #MountSinaiMedicalCenter #Surgeon #Teacher #ThyroidNodules #RadioactiveIodine #RAI #PTC #MSMC